Li Ka Shing Faculty of Medicine, The University of Hong Kong, China.
Department of Pharmacology and Pharmacy, The University of Hong Kong, China.
J Gerontol A Biol Sci Med Sci. 2020 Apr 17;75(5):980-986. doi: 10.1093/gerona/glz178.
To evaluate whether the common risk factors and risk scores (FRAX, QFracture, and Garvan) can predict hip fracture in the oldest old (defined as people aged 80 and older) and to develop an oldest-old-specific 10-year hip fracture prediction risk algorithm.
Subjects aged 80 years and older without history of hip fracture were studied. For the derivation cohort (N = 251, mean age = 83), participants were enrolled with a median follow-up time of 8.9 years. For the validation cohort (N = 599, mean age = 85), outpatients were enrolled with a median follow-up of 2.6 years. A five-factor risk score (the Hong Kong Osteoporosis Study [HKOS] score) for incident hip fracture was derived and validated, and its predictive accuracy was evaluated and compared with other risk scores.
In the derivation cohort, the C-statistics were .65, .61, .65, .76, and .78 for FRAX with bone mineral density (BMD), FRAX without BMD, QFracture, Garvan, and the HKOS score, respectively. The category-less net reclassification index and integrated discrimination improvement of the HKOS score showed a better reclassification of hip fracture than FRAX and QFracture (all p < .001) but not Garvan, while Garvan, but not HKOS score, showed a significant over-estimation in fracture risk (Hosmer-Lemeshow test p < .001). In the validation cohort, the HKOS score had a C-statistic of .81 and a considerable agreement between expected and observed fracture risk in calibration.
The HKOS score can predict 10-year incident hip fracture among the oldest old in Hong Kong. The score may be useful in identifying the oldest old patients at risk of hip fracture in both community-dwelling and hospital settings.
评估常见的风险因素和风险评分(FRAX、QFracture 和 Garvan)是否可以预测最年长老年人(定义为 80 岁及以上的人群)的髋部骨折,并制定最年长老年人 10 年髋部骨折预测风险算法。
研究了年龄在 80 岁及以上且无髋部骨折史的受试者。在推导队列(N=251,平均年龄 83 岁)中,参与者的中位随访时间为 8.9 年。在验证队列(N=599,平均年龄 85 岁)中,招募了门诊患者,中位随访时间为 2.6 年。推导并验证了一个用于预测髋部骨折的五因素风险评分(香港骨质疏松症研究 [HKOS] 评分),并评估了其预测准确性,并与其他风险评分进行了比较。
在推导队列中,FRAX 联合骨密度(BMD)、FRAX 不联合 BMD、QFracture、Garvan 和 HKOS 评分的 C 统计量分别为.65、.61、.65、.76 和.78。HKOS 评分的类别无净重新分类指数和综合鉴别改善表明,与 FRAX 和 QFracture 相比,髋部骨折的再分类更好(均 p<0.001),但与 Garvan 相比并非如此,而 Garvan 则表明骨折风险存在显著高估(Hosmer-Lemeshow 检验 p<0.001)。在验证队列中,HKOS 评分的 C 统计量为.81,并且在校准中观察到的骨折风险之间具有相当的一致性。
在香港,HKOS 评分可预测最年长老年人的 10 年髋部骨折事件。该评分可能有助于在社区和医院环境中识别最年长的老年髋部骨折高危患者。